Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 8
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4044)
- Volume 19, 2023 (187)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 8, 2012
Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases
Nisijima K
Neuropsychiatric Disease and Treatment 2012, 8:615-618
Published Date: 13 December 2012
Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
Gérard A, Liard F, Crochard A, Goni S, Millet B
Neuropsychiatric Disease and Treatment 2012, 8:605-614
Published Date: 13 December 2012
The association of drooling and health-related quality of life in children with cerebral palsy
Chang SC, Lin CK, Tung LC, Chang NY
Neuropsychiatric Disease and Treatment 2012, 8:599-604
Published Date: 11 December 2012
Psychogenic nonepileptic seizures: a treatment review. What have we learned since the beginning of the millennium?
Baslet G
Neuropsychiatric Disease and Treatment 2012, 8:585-598
Published Date: 10 December 2012
Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
Yamamoto H, Tsuchida H, Nakamae T, Nishida S, Sakai Y, Fujimori A, Narumoto J, Wada Y, Yoshida T, Taga C, Fukui K
Neuropsychiatric Disease and Treatment 2012, 8:579-583
Published Date: 6 December 2012
Galantamine versus donepezil in Chinese patients with Alzheimer’s disease: results from a randomized, double-blind study
Zhang Z, Yu L, Gaudig M, Schäuble B, Richarz U
Neuropsychiatric Disease and Treatment 2012, 8:571-577
Published Date: 4 December 2012
Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents
Watanabe N, Nishida A, Shimodera S, Inoue K, Oshima N, Sasaki T, Inoue S, Akechi T, Furukawa TA, Okazaki Y
Neuropsychiatric Disease and Treatment 2012, 8:561-569
Published Date: 22 November 2012
Reproductive life events and Alzheimer’s disease in Italian women: a retrospective study
Zucchella C, Sinforiani E, Citterio A, Giarracca V, Bono G, Mauri M
Neuropsychiatric Disease and Treatment 2012, 8:555-560
Published Date: 21 November 2012
Usefulness of milnacipran in treating phantom limb pain
Nagoshi Y, Watanabe A, Inoue S, Kuroda T, Nakamura M, Matsumoto Y, Fukui K
Neuropsychiatric Disease and Treatment 2012, 8:549-553
Published Date: 20 November 2012
Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the Facial Action Coding System: a preliminary study
Bersani G, Bersani FS, Valeriani G, Robiony M, Anastasia A, Colletti C, Liberati D, Capra E, Quartini A, Polli E
Neuropsychiatric Disease and Treatment 2012, 8:537-547
Published Date: 18 December 2012
Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
El-Khalili N
Neuropsychiatric Disease and Treatment 2012, 8:523-536
Published Date: 8 November 2012
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
Kristinsson J, Snaedal J, Tórsdóttir G, Jóhannesson T
Neuropsychiatric Disease and Treatment 2012, 8:515-521
Published Date: 2 November 2012
Can headache impair intellectual abilities in children? An observational study
Esposito M, Pascotto A, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Gritti A, Mazzotta G, Carotenuto M
Neuropsychiatric Disease and Treatment 2012, 8:509-513
Published Date: 1 November 2012
Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kato A, Kusumi I, Koyama T
Neuropsychiatric Disease and Treatment 2012, 8:501-507
Published Date: 30 October 2012
Effects of repetitive transcranial magnetic stimulation on clinical, social, and cognitive performance in postpartum depression
Myczkowski ML, Dias AM, Luvisotto T, Arnaut D, Bellini BB, Mansur CG, Rennó J, Tortella G, Ribeiro PL, Marcolin MA
Neuropsychiatric Disease and Treatment 2012, 8:491-500
Published Date: 25 October 2012
Outcomes analysis of Internet-based CME initiatives for diagnosis and treatment of fibromyalgia patients: transition from education to physician behavior to patient health
Somasekhar MM, Berney S, Rausch C, Degnan J
Neuropsychiatric Disease and Treatment 2012, 8:483-489
Published Date: 23 October 2012
Effectiveness of sensory processing strategies on activity level in inclusive preschool classrooms
Lin CL, Min YF, Chou LW, Lin CK
Neuropsychiatric Disease and Treatment 2012, 8:475-481
Published Date: 23 October 2012
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?
Mezei Z, Bereczki D, Racz L, Csiba L, Csepany T
Neuropsychiatric Disease and Treatment 2012, 8:465-473
Published Date: 23 October 2012
New developments in the treatment of partial-onset epilepsy
Besag FM, Patsalos PN
Neuropsychiatric Disease and Treatment 2012, 8:455-464
Published Date: 17 October 2012
EACOL (Scale of Evaluation of Reading Competence by the Teacher): evidence of concurrent and discriminant validity
Cogo-Moreira H, Ploubidis GB, de Ávila CR, Mari JJ, Pinheiro AM
Neuropsychiatric Disease and Treatment 2012, 8:443-454
Published Date: 11 October 2012
Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
Skogar Ö, Fall P-A, Hallgren G, Bringer B, Carlsson M, Lennartsson U, Sandbjörk H, Törnhage C-J, Lökk J
Neuropsychiatric Disease and Treatment 2012, 8:435-442
Published Date: 12 October 2012
Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine
Vikelis M, Mitsikostas DD, Rapoport AM
Neuropsychiatric Disease and Treatment 2012, 8:429-434
Published Date: 26 September 2012
Stimulus-dependent effects on right ear advantage in schizophrenia
Smucny J, Wylie K, Tregellas J
Neuropsychiatric Disease and Treatment 2012, 8:423-427
Published Date: 21 September 2012
Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression
Santos T, Baungratz MM, Haskel SP, de Lima DD, da Cruz JN, Dal Magro DD, da Cruz JG
Neuropsychiatric Disease and Treatment 2012, 8:413-422
Published Date: 1 October 2012
Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study
Ghaleiha A, Jahangard L, Sherafat Z, Ahmadpanah M, Brand S, Holsboer-Trachsler E, Bajoghli H, Haghighi M
Neuropsychiatric Disease and Treatment 2012, 8:407-412
Published Date: 14 September 2012
Reducing serum cholesterol levels in women
Lozano R
Neuropsychiatric Disease and Treatment 2012, 8:405-406
Published Date: 12 September 2012
Chronic shoulder pain referred from thymic carcinoma: a case report and review of literature
Dee SW, Kao MJ, Hong CZ, Chou LW, Lew HL
Neuropsychiatric Disease and Treatment 2012, 8:399-403
Published Date: 4 September 2012
Twelve-month, prospective, open-label study of repetitive transcranial magnetic stimulation for major depressive disorder in partial remission
Charnsil C, Suttajit S, Boonyanaruthee V, Leelarphat S
Neuropsychiatric Disease and Treatment 2012, 8:393-397
Published Date: 30 August 2012
OPLS statistical model versus linear regression to assess sonographic predictors of stroke prognosis
Fathi Vajargah K, Sadeghi-Bazargani H, Mehdizadeh-Esfanjani R, Savadi-Oskouei D, Farhoudi M
Neuropsychiatric Disease and Treatment 2012, 8:387-392
Published Date: 30 August 2012
Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
Sliwa JK, Bossie CA, Fu D-J, Turkoz I, Alphs L
Neuropsychiatric Disease and Treatment 2012, 8:375-385
Published Date: 27 August 2012
Depressive symptoms and childhood sleep apnea syndrome
Carotenuto M, Esposito M, Parisi L, Gallai B, Marotta R, Pascotto A, Roccella M
Neuropsychiatric Disease and Treatment 2012, 8:369-373
Published Date: 23 August 2012
Transdermal donepezil on the treatment of Alzheimer's disease
Sozio P, Cerasa LS, Marinelli L, Di Stefano A
Neuropsychiatric Disease and Treatment 2012, 8:361-368
Published Date: 20 August 2012
Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
Abrahamian H, Hofmann P, Kinzl J, Toplak H
Neuropsychiatric Disease and Treatment 2012, 8:355-360
Published Date: 14 August 2012
Aggressive behavior, cognitive impairment, and depressive symptoms in elderly subjects
Margari F, Sicolo M, Spinelli L, Mastroianni F, Pastore A, Craig F, Petruzzelli MG
Neuropsychiatric Disease and Treatment 2012, 8:347-353
Published Date: 1 August 2012
Acute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports
Akahoshi K, Matsuda H, Funahashi M, Hanaoka T, Suzuki Y
Neuropsychiatric Disease and Treatment 2012, 8:339-345
Published Date: 30 July 2012
Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
Armaly Z, Farah J, Jabbour A, Bisharat B, Abd-El Qader A, Saba S, Zaher M, El Haj E, Hamzi M, Bowirrat A
Neuropsychiatric Disease and Treatment 2012, 8:329-338
Published Date: 25 July 2012
5-HTP efficacy and contraindications
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2012, 8:323-328
Published Date: 19 July 2012
Editor's choice
Pinder RM
Neuropsychiatric Disease and Treatment 2012, 8:321-322
Published Date: 20 July 2012
Pattern sensitivity: a missed part of the diagnosis
El Shakankiry HM, Abdel Kader AA
Neuropsychiatric Disease and Treatment 2012, 8:313-319
Published Date: 17 July 2012
Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
Endicott J, Svedsäter H, Locklear JC
Neuropsychiatric Disease and Treatment 2012, 8:301-311
Published Date: 11 July 2012
Copy number variants in a sample of patients with psychotic disorders: is standard screening relevant for actual clinical practice?
Van de Kerkhof NW, Feenstra I, van der Heijden FM, De Leeuw N, Pfundt R, Stöber G, Egger JI, Verhoeven WM
Neuropsychiatric Disease and Treatment 2012, 8:295-300
Published Date: 12 July 2012
Adjunctive therapy in Parkinson's disease: the role of rasagiline
Gaines KD, Hinson VK
Neuropsychiatric Disease and Treatment 2012, 8:285-294
Published Date: 2 July 2012
Measuring severe adverse events and medication selection using a “PEER Report” for nonpsychotic patients: a retrospective chart review
Hoffman DA, DeBattista C, Valuck RJ, Iosifescu DV
Neuropsychiatric Disease and Treatment 2012, 8:277-284
Published Date: 21 June 2012
Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study
Biederman J, Spencer TJ, Petty C, Hyder LL, O'Connor KB, Surman CBH, Faraone SV
Neuropsychiatric Disease and Treatment 2012, 8:267-276
Published Date: 25 June 2012
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
Ye W, Ascher-Svanum H, Tanji Y, Flynn JA, Takahashi M, Conley RR
Neuropsychiatric Disease and Treatment 2012, 8:259-266
Published Date: 18 June 2012
Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
Cazorla P, Mackle M, Zhao J, Ha X, Szegedi A
Neuropsychiatric Disease and Treatment 2012, 8:247-257
Published Date: 15 June 2012
Influence of drug treatment with antidepressants and antipsychotics on plasma urea levels
Lozano Ortiz R
Neuropsychiatric Disease and Treatment 2012, 8:245-246
Published Date: 11 June 2012
Role of aripiprazole in treatment-resistant schizophrenia
Mossaheb N, Kaufmann RM
Neuropsychiatric Disease and Treatment 2012, 8:235-244
Published Date: 29 May 2012
Sleep paralysis in medieval Persia – the Hidayat of Akhawayni (? –983 AD)
Golzari SE, Khodadoust K, Alakbarli F, Ghabili K, Islambulchilar Z, Shoja MM, Khalili M, Abbasnejad F, Sheikholeslamzadeh N, Shahabi NM, Hosseini SF, Ansarin K,
Neuropsychiatric Disease and Treatment 2012, 8:229-234
Published Date: 6 June 2012
Teenage outcomes after speech and language impairment at preschool age
Ek U, Norrelgen F, Westerlund J, Dahlman A, Hultby E, Fernell E
Neuropsychiatric Disease and Treatment 2012, 8:221-227
Published Date: 15 May 2012
Effect of rehabilitation on a patient suffering from a tuberculous brain abscess with Gerstmann's syndrome: case report
Kuo CL, Lo SF, Liu CL, Chou CH, Chou LW
Neuropsychiatric Disease and Treatment 2012, 8:217-220
Published Date: 7 May 2012
Optimal treatment of social phobia: systematic review and meta-analysis
Canton J, Scott KM, Glue P
Neuropsychiatric Disease and Treatment 2012, 8:203-215
Published Date: 3 May 2012
Cortical mapping with navigated transcranial magnetic stimulation in low-grade glioma surgery
Paiva WS, Fonoff ET, Marcolin MA, Cabrera HN, Teixeira MJ
Neuropsychiatric Disease and Treatment 2012, 8:197-201
Published Date: 3 May 2012
The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy
Sterjev Z, Trencevska GK, Cvetkovska E, Petrov I, Kuzmanovski I, Ribarska JT, Nestorovska AK, Matevska N, Naumovska Z, Jolevska-Trajkovic S, Dimovski A, Suturkova L
Neuropsychiatric Disease and Treatment 2012, 8:191-196
Published Date: 19 April 2012
The role of paliperidone extended release for the treatment of bipolar disorder
Marino J, English C, Caballero J, Harrington C
Neuropsychiatric Disease and Treatment 2012, 8:181-189
Published Date: 20 April 2012
Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?
Verhoeven WMA, Egger JIM, Willemsen MH, de Leijer GJM, Kleefstra T
Neuropsychiatric Disease and Treatment 2012, 8:175-179
Published Date: 19 April 2012
Is this a new type of primary prosopagnosia, both progressive and apperceptive?
Sugimoto A, Koyama S, Midorikawa A, Futamura A, Ishiwata K, Ishii K, Miller MW, Kawamura M
Neuropsychiatric Disease and Treatment 2012, 8:169-173
Published Date: 18 April 2012
Critical appraisal of lurasidone in the management of schizophrenia
Caccia S, Pasina L, Nobili A
Neuropsychiatric Disease and Treatment 2012, 8:155-168
Published Date: 17 April 2012
Preliminary pilot fMRI study of neuropostural optimization with a noninvasive asymmetric radioelectric brain stimulation protocol in functional dysmetria
Mura M, Castagna A, Fontani V, Rinaldi S
Neuropsychiatric Disease and Treatment 2012, 8:149-154
Published Date: 4 April 2012
Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice
Seibert J, Tracik F, Articus K, Spittler S
Neuropsychiatric Disease and Treatment 2012, 8:141-147
Published Date: 5 April 2012
Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment
Boscarino JA, Erlich PM, Hoffman SN, Zhang X
Neuropsychiatric Disease and Treatment 2012, 8:131-139
Published Date: 23 March 2012
Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
Singh M, Schwartz TL
Neuropsychiatric Disease and Treatment 2012, 8:123-130
Published Date: 23 March 2012
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
Goto N, Yoshimura R, Kakeda S, Nishimura J, Moriya J, Hayashi K, Katsuki A, Hori H, Umene-Nakano W, Ikenouchi-Sugita A, Korogi Y, Nakamura J
Neuropsychiatric Disease and Treatment 2012, 8:119-122
Published Date: 3 April 2012
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K
Neuropsychiatric Disease and Treatment 2012, 8:113-118
Published Date: 15 March 2012
Hearing voices: does it give your patient a headache? A case of auditory hallucinations as acoustic aura in migraine
Van der Feltz-Cornelis CM, Biemans H, Timmer J
Neuropsychiatric Disease and Treatment 2012, 8:105-111
Published Date: 14 March 2012
Update on the role of antipsychotics in the treatment of Tourette syndrome
Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J
Neuropsychiatric Disease and Treatment 2012, 8:95-104
Published Date: 12 March 2012
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I
Neuropsychiatric Disease and Treatment 2012, 8:85-93
Published Date: 9 February 2012
Neuroimmune endocrine effects of antidepressants
Antonioli M, Rybka J, Carvalho LA
Neuropsychiatric Disease and Treatment 2012, 8:65-83
Published Date: 7 February 2012
ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review
Minichino A, Bersani FS, Capra E, Pannese R, Bonanno C, Salviati M, Delle Chiaie R, Biondi M
Neuropsychiatric Disease and Treatment 2012, 8:55-64
Published Date: 16 January 2012
A case of mistaken identity: alcohol withdrawal, schizophrenia, or central pontine myelinolysis?
Schneider P, Nejtek VA, Hurd CL
Neuropsychiatric Disease and Treatment 2012, 8:49-54
Published Date: 1 February 2012
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
Robertson CE, Garza I
Neuropsychiatric Disease and Treatment 2012, 8:35-48
Published Date: 13 January 2012
Reduced reward-related probability learning in schizophrenia patients
Yılmaz A, Simsek F, Gonul AS
Neuropsychiatric Disease and Treatment 2012, 8:27-34
Published Date: 5 January 2012
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
Jimenez-Shahed J
Neuropsychiatric Disease and Treatment 2012, 8:13-25
Published Date: 23 December 2011
Electroencephalography in eating disorders
Jáuregui-Lobera I
Neuropsychiatric Disease and Treatment 2012, 8:1-11
Published Date: 28 December 2011